Novartis AG is considering the sale of its contact lens care products as the Swiss drugmaker seeks to improve growth at its eye-care unit, Alcon, according to people with knowledge of the matter.
The lens-care business may draw interest from competitors, the people said, asking not to be identified because the deliberations are private. The proposed sale is at a preliminary stage and the company may decide against a disposal, the people said.
The lens-care business may draw interest from competitors, the people said, asking not to be identified because the deliberations are private. The proposed sale is at a preliminary stage and the company may decide against a disposal, the people said.
